Is oral cancer unique in terms of chemotherapeutic and targeted drug metabolism?

Journal of Oral and Maxillofacial Surgery

Volumn 73, Issue 1, 2015, Pages 4-6

  Sarode, Sachin C ^a   Sarode, Gargi S ^a  

^a DR D Y PATIL DENTAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; AUTACOID; C REACTIVE PROTEIN; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450 3A; CYTOKINE;

ADJUVANT CHEMORADIOTHERAPY; ADVANCED CANCER; DRUG METABOLISM; DRUG RESISTANCE; DRUG TARGETING; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MOUTH CANCER; MOUTH HYGIENE; PATHOGENESIS; REVIEW; CARCINOMA, SQUAMOUS CELL; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOLECULARLY TARGETED THERAPY; MOUTH; MOUTH NEOPLASMS; PRECANCER; PROCEDURES; RISK ASSESSMENT; RISK FACTOR;

ANTINEOPLASTIC AGENTS; C-REACTIVE PROTEIN; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY, ADJUVANT; CYTOCHROME P-450 CYP3A; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; MOLECULAR TARGETED THERAPY; MOUTH; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; RISK ASSESSMENT; RISK FACTORS;

EID: 84916920232     PISSN: 02782391     EISSN: 15315053     Source Type: Journal    
DOI: 10.1016/j.joms.2014.09.017     Document Type: Article

References (5)

1. K.A. Slaviero, S.J. Clarke, and L.P. Rivory Inflammatory response: An unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy Lancet Oncol 4 2003 224
2. R. Lu, J. Zhang, W. Sun, G. Du, and G. Zhou Inflammation-related cytokines in oral lichen planus: An overview J Oral Pathol Med 2013 10.1111/jop.12142
3. M.F. Haque, S. Meghji, U. Khitab, and M. Harris Oral submucous fibrosis patients have altered levels of cytokine production J Oral Pathol Med 29 2000 123
4. J.K. Pietruski, M.D. Pietruska, and E. Jabłońska Interleukin 6, tumor necrosis factor alpha and their soluble receptors in the blood serum of patients with denture stomatitis and fungal infection Arch Immunol Ther Exp (Warsz) 48 2000 101
5. Z. Chen, P.S. Malhotra, and G.R. Thomas Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer Clin Cancer Res 5 1999 1369